The Nebraska Center for Rapid Bioanalysis An Overview of the UNMC current COBRE centers and Nanoimaging core facilityAn Overview of the UNMC current COBRE.

Slides:

Advertisements

Similar presentations

Howard E. Gendelman, MD Larson Professor of Medicine and Infectious Diseases Chairman, Department of Pharmacology and Experimental Neuroscience Director,

Advertisements

Miami CTSI--Culturalized Health Sciences for a Healthier South Florida! Clinical & Translational Science Institutes The U.S.A. launches an initiative to.

Develop and Utilize Human Potential 1. Qatar Research Institutes.

Overview of Mentored K Awards Shawna V. Hudson, PhD Assistant Professor of Family Medicine and Community Health UMDNJ-RWJMS The Cancer Institute of New.

What’s NIH? National Cancer Institute National Eye Institute National Heart, Lung, and Blood Inst. National Human Genome Research Inst National Institute.

Single Molecule Imaging and Tracking for High-Throughput Screening Single Molecule Imaging and Tracking for High-Throughput Screening Greg Bashford Dept.

European Cooperation in the field of Scientific and Technical Research COST is supported by the EU RTD Framework Programme ESF provides the COST Office.

1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.

Bioscience/Biomedical Research at Idaho State University Christopher Daniels, Ph.D. Director, ISU Biomedical Research Institute and Professor of Pharmaceutical.

Educational Programs in Bioinformatics at UNO Hesham H. Ali Department of Computer Science College of Info Science and Technology University of Nebraska.

Helena Chui, M.D. McCarron Professor and Chair of Neurology Director, Alzheimer Disease Research Center.

Wellcome Trust - Funding the best science

Bindley Bioscience Center Vision: Nurture interactive communication and interdisciplinary discovery with flexible laboratory project spaces and an open.

NICLS: Development of Biomedical Computing and Information Technology Infrastructure Presented by Simon Sherman August 15, 2005.

Rapid detection of drugs for protein misfolding diseases. Alexey Krasnoslobodtsev, Department of Pharmaceutical Sciences, University of Nebraska Medical.

Challenges in Clinical Applications for Nanotechnology N. Tony Eissa, MD Table 3.

The Application of the Scientific Method: Preclinical Trials Copyright PEER.tamu.edu.

Overview of UNMC Campus Research Activities Howard E. Gendelman, M.D. Professor and Chair, Pharmacology and Experimental Neuroscience, UNMC Howard E. Gendelman,

MINORITY OPPORTUNITIES IN RESEARCH NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES Division of Minority Opportunities in Research.

1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical development Phase I Phase II Phase III Product.

Molecular Library and Imaging Francis Collins, NHGRI Tom Insel, NIMH Rod Pettigrew, NIBIB Building Blocks and Pathways Francis Collins,NHGRI Richard Hodes,

Department of Biological Sciences (In the Fairmount College of Liberal Arts and Sciences) Chair: William J. Hendry, Ph.D.

Dr. Sylvia Oliver PLTW Biomedical Science Affiliate Director WSU Spokane

Johnny Wynne College of Agriculture & Life Sciences Research Retreat February 26-28, 2003.

Building the Multidisciplinary Nanomedicine Team: a Case Study Guangzhao Mao Department of Chemical Engineering and Materials Science.

Institute of Living Systems.  Neuroscience Center  Laboratory of Stem Cells Research and Regenerative Medicine  Laboratory of Experimental Oncology.

Pharmacology embraces knowledge of the sources, chemical properties, biological effects and therapeutic uses of drugs. In general terms, pharmacology.

Florida Center of Excellence for Biomolecular Identification and Targeted Therapeutics.

ENGINEERING ORIENTATION Information on Bioengineering Curriculum and Area Electives Dr. A. Saterbak Dr. K.-Y. San.

Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.

Partnering with Federal Labs: A Panel Discussion FLC Mid-Atlantic Region Annual Meeting October 24, 2007.

Public/Private Partnerships in Neuroscience and The George & Ann Ryan Neuroscience Institute.

KI’s new laboratory: Biomedicum – research without boundaries.

Funding Opportunities at the NIH and the National Institute of Biomedical Imaging and Bioengineering Grace C.Y. Peng, Ph.D. March 19, st annual ORNL.

Frontier Research Program on Molecular Destruction and Reconstruction of Tooth and Bone Masaki Noda,M.D.,Ph.D. Program Leader Professor Department of Molecular.

A New Oklahoma Bioinformatics Company. Microarray and Bioinformatics.

Translational Science in Cancer Health Disparities Research Peter Ujhazy, M.D., Ph.D. Program Director Translational Research Program Division of Cancer.

Biomarkers and Drug Discovery Angie Pannier Mathias Schubert Pat Dussault Surinder Batra.

Center for Biologics Evaluation and Research Carolyn A. Wilson, Ph.D. Associate Director for Research Applying Regulatory Science to Advance Development.

Academic Pathway Pharmaceutical Sciences NTUSPAA-NA Annual Event San Francisco, CA, August 6, 2005 Diana Shu-Lian Chow, Ph.D. Associate Professor of Pharmaceutics.

Susan R. Kayar, PhD Health Scientist Administrator Research Infrastructure NCRR, NIH Funding Opportunities through the National Center for Research Resources.

ROC RETREAT February 3-4, 2005 Neil C. Olson, DVM, PhD Associate Dean For Research & Graduate Studies Director of CVM BioPark & Facilities Development.

ECCR Overview/MLSCN. NIH Roadmap Series of initiatives designed to pursue major opportunities in biomedical research and gaps in current knowledge that.

Proteomics: Protein Profiling and Identification through Mass Spectrometry Vermont Genetics Network Proteomics Outreach Program.

Robert H. Wiltrout Director, CCR Director’s Address.

Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.

Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.

Nanotechnology involves the creation and use of materials and devices at the level of molecules and atoms. Nanomedicine, an offshoot of nanotechnology,

Sneaking spies into a cell's nucleus Duke University bioengineers have not only figured out a way to sneak molecular spies through the walls of individual.

Promise of CNS drug delivery Immersion Studios, Inc. “Lung Nanorobots I” (2001) Alexander Kabanov Parke-Davis Professor of Pharmaceutical Sciences Director,

School of Mechanical, Materials and Manufacturing Engineering About this course Biomedical industries provide a rich diversity.

GLOBAL ENGAGEMENT OFFICE West Virginia University Health Sciences Center.

One Room, Many Doors: Logistics of Recruiting and Training Students in Neuroscience through an Undifferentiated Biomedical Program.

The evaluator point of view…. “IDEAS, ERC Starting Grant 2007” Henriette Molinari Department of Biotechnology University of Verona.

A model collaboration using the Pool Susanne Hollinger, Ph.D., J.D. Chief Intellectual Property Officer Emory University.

Convergence of Nanotechnology and Cardiovascular Medicine Harsharan Pal Singh 1 *, Ishpreet Kaur 2 1 Department of Pharmacology & Toxicology, Noida Institute.

TITIN ANDRI WIHASTUTI SCHOOL OF NURSING FACULTY OF MEDICINE

Nanomedicine Research at OU

Bridging Biomedical Research

Brain Barrier Research Center:

Yale SPORE in Skin Cancer

Development of a Research Proposal: The COBRE Saga

Morris A. Washington Professor of Practice, Dept. of Physics, Applied Physics & Astronomy Director, Micro and Nano Fabrication Clean Room Associate Director,

National and International Efforts worth knowing about

Nicholas P. Ambulos, PhD Director, CIBR October 24, 2017

Biomedical Sciences Pathway

From Bench to Clinical Applications: Money Talks

TEXAS STATE UNIVERSITY HEALTH SCHOLAR SHOWCASE

Cecil and Ida Green Distinguished Professor

MD Tech Council – Doing Biz w/ NIH

Presentation transcript:

The Nebraska Center for Rapid Bioanalysis An Overview of the UNMC current COBRE centers and Nanoimaging core facilityAn Overview of the UNMC current COBRE centers and Nanoimaging core facility Yuri Lyubchenko COBRE Retreat - January 16, 2009

Nebraska Center for Cellular Signaling PI: Peggy Wheelock, Ph.D. First COBRE grant was received in This CoBRE grant was to establish a center for cellular signaling that will function to bring together senior investigators to serve as mentors for junior investigators. Five junior investigator projects are funded on this grant and the goal was to assist these investigators in securing independent funding for their work.

Nebraska Center for Cellular Signaling PI: Peggy Wheelock, Ph.D. July 2008: NIH renews Dr. Wheelock's CoBRE grant the winning formula Peggy Wheelock - to have two high profile researchers as mentors for five years. seven junior investigators at UNMC obtained their own RO1 grants from the National Institutes of Health (NIH). This success has led to the NIH approving a renewal of Dr. Wheelock's Centers of Biomedical Research Excellence (CoBRE) grant for another five years at $10.9 million. Peggy Wheelock: The grant has allowed us to bring together outstanding junior and senior faculty with similar interests, which greatly enhances the science knowledge and opportunities for collaboration."

Nebraska Center for Nanomedicine Dr. Kabanov, the Parke-Davis Chair in Pharmaceutics, UNMC College of Pharmacy, is the director of the Nebraska Center for Nanomedicine Funding - $10.6 M "This grant allows us to attract the best and brightest scientists to Nebraska, to develop novel technologies that could contribute to the economy of the state with the help of spin-off companies that would bring the results of the scientific research to public use," Dr. Kabanov said.

Nebraska Center for Nanomedicine Nanomedicine defines the emerging area of science that uses nanomaterials, small polymeric particles to deliver drugs safely to disease sites, such as cancer tumors.

Center of Drug Deliver and Nanomedicine (CDDN) This regent-approved Center was established to support an interdisciplinary team of scientists with specific expertise in nanomedicine, drug delivery, therapeutics, and diagnostics. Nanomedicine is a medical intervention at the molecular scale for curing disease or repairing damaged tissue.

Nebraska Center for Nanomedicine The four projects currently being supported through the COBRE funding are as follows. Project 1: Principal investigator: Elena V. Batrakova, Ph.D., assistant professor of pharmaceutical sciences. Mentor: Howard Gendelman, M.D., chairman, department of pharmacology and experimental neuroscience, director, Center for Neurovirology and Neurodegenerative Disorders. Dr. Batrakova's project focuses on creating a drug delivery system to treat Parkinson's disease using nanozymes and immune cells in the brain as the delivery agent. Nanozymes are tiny particles consisting of an enzyme in a protective polymer coat. Project 2: Principal investigator: Matthew Zimmerman, Ph.D., assistant professor of cellular and integrative physiology. Mentor: Irving Zucker, Ph.D., professor and chairman of the cellular and integrative physiology department. Dr. Zimmerman's research project focuses on using antioxidant therapy and nanozymes to treat hypertension. Project 3: Principal investigator: Huanyu Dou, Ph.D., assistant professor, department of pharmacology and experimental neuroscience. Mentor: Surinder Batra, Ph.D., professor in the department of biochemistry and molecular biology. Dr. Dou's research project focuses on developing a cell-based nanoformulated anti-tumor therapy that would improve biodistribution of the drug to the tumor and reduce chemotherapy-induced neurotoxicity. Project 4: Principal investigator: Joseph Vetro, Ph.D., assistant professor, Center for Drug Delivery and Nanomedicine, department of pharmaceutical sciences. Mentor: Alexander Kabanov, Ph.D., director, Nebraska Center for Nanomedicine. Dr. Vetro's research focuses on inhibiting the growth of cancer tumors by using specially developed nanocarrierse that disrupt the tumor's ability to recruit surrounding blood vessels.

UNMC Shared Resources/Core Facilities Mass Spectrometry and Proteomics Core Facility Nanoimaging Core Facility

The facility is equipped with three instruments: The combination state of the art AFM microscope (Asylum Research Veeco, Santa Brabara, CA) mounted on an inverted fluorescence microscope (Olympus), allowing simultaneous detection of fluorescently labeled samples, high resolution AFM imaging, force spectroscopy, and manipulation at the nanoscale. The stand-alone AFM (MM AFM, Veeco, Santa Brabara, CA), capable of high-resolution imaging of various biological samples in air and aqueous solution. AFM force robot (JPK Germany) allowing automate acqusition of the data on the intermolecular interactions various molecular systems The facility provides expertise for researchers in imaging, force spectroscopy analysis, elasticity measurements and other applications of Atomic Force Microscopy

AFM-optical microscope

MM AFM microscope

JPK Force Robot Force Spectrosope Head User PC with ForceRobot Software Stable base frame with active vibration isolation Force Spectroscope Base Controller with TCP/IP-Interface

Nebraska Center for Cellular Signaling PI: Peggy Wheelock, Ph.D. July 2008: NIH renews Dr. Wheelock's CoBRE grant the winning formula Peggy Wheelock - to have two high profile researchers as mentors for five years. seven junior investigators at UNMC obtained their own RO1 grants from the National Institutes of Health (NIH). This success has led to the NIH approving a renewal of Dr. Wheelock's Centers of Biomedical Research Excellence (CoBRE) grant for another five years at $10.9 million

UNMC: New Potential projects

LC-MS Determination of Bile Acid-Sulfates As Biomarkers for Liver Function Yazen Alnouti, Ph.D Assistant Professor Department of Pharmaceutical Sciences University of Nebraska Medical Center

BA Enterohepatic Recirculation 95% Under normal conditions, BAs are contained within the enteroheaptic system, spill over into blood is minimum, and urinary excretion is negligible

Rapid detection of drugs for protein misfolding diseases. Alexey Krasnoslobodtsev, Department of Pharmaceutical Sciences, University of Nebraska Medical Center COBRE 16 January, 2009

Conformational prerequisites for amyloidosis

Center for Pharmaceutical Biophysics The research outcomes of the Center will serve as the basis for the discovery of diagnostic agents and new pharmaceutical entities for the prevention, treatment and/or cure of diseases. The Center’s mission is to unite efforts of researchers working in the areas of basic and applied pharmaceutical and biomedical sciences, chemistry, biochemistry, and engineering who are exploring and developing new technologies for the analysis of biological nanosystems in such biopharmaceutical science fields as high- throughput screening of drugs, drug development, diagnostics, therapeutics, single molecule imaging/tracking and biomarker assays.